Robert Shaw
Robert M. Shaw
General Counsel

Robert M. Shaw is an intellectual property lawyer who served for many years as in-house counsel at prominent pharmaceutical, biotechnology and chemical companies. He brings an invaluable ‘client-side’ perspective to Kenyon, which he leverages in order to advise firm clients on commercial transactions, due diligence, dispute resolution, IP strategies, and patent validity and infringement. Having served as General Counsel, Deputy General Counsel, Vice President of Intellectual Property, and Chief Administrative Officer at leading global companies, Mr. Shaw has proven experience developing IP strategies which help improve efficiencies and increase profitability. He also possesses substantial experience in interacting with government agencies on compliance issues and investigations. 

Mr. Shaw also serves as the General Counsel to Kenyon & Kenyon.

Prior to joining the firm, Mr. Shaw served as Vice President, Deputy General Counsel and Secretary for K-V Pharmaceutical Company, a brand and generic pharmaceutical manufacturer. Prior to that, Mr. Shaw served as Senior Vice President, General Counsel and Secretary at Pliva, Inc., the United States subsidiary of a billion dollar brand and generic pharmaceutical company and API supplier and, prior to that, as Executive Vice President, General Counsel and Secretary, as well as Chief Administrative Officer at Savient Pharmaceuticals, Inc., a biotechnology company.

Earlier in his career, Mr. Shaw served as the Vice President of Intellectual Property at BASF Corporation. Prior to moving in-house, Mr. Shaw spent five years as an attorney at IP boutique law firms.

bar and court admissions
  • New York
  • Pennsylvania
  • Missouri
  • U.S. District Court for the Southern District of New York
  • U.S. District Court for the Eastern District of New York
  • U.S. District Court for the Eastern District of Pennsylvania
  • U.S. District Court for the Western District of Missouri
  • U.S. Court of Appeals for the Third Circuit
  • U.S. Court of Appeals for the Federal Circuit
  • U.S. Patent and Trademark Office